Imara Inc expected to post a loss of 58  cents a share - Earnings Preview

Enliven Therapeutics

06/05/2022 19:31

* Imara Inc  IMRA.OQ   IMRA.O  is expected to show no change
in
quarterly revenue when it reports  results on May 9
(estimated). 
    * ​Refinitiv's mean analyst estimate for Imara Inc is for a
loss
of 58 cents per share. For the same quarter last year, the
company reported a loss of 58 cents per share.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Imara Inc
is $2​,
above​ its last closing price of $1.31. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.79       -0.75      -0.53     Beat    29.4
 Sep. 30 2021  -0.73       -0.85      -0.55     Beat    35
 Jun. 30 2021  -0.75       -0.80      -0.74     Beat    7.6​
 Mar. 31 2021  -0.82       -0.83      -0.58     Beat    30.5
 ​​Dec.        -0.84       -0.84      -0.56     Beat    33.2
 31 2020                                                
 Sep. 30 2020  -0.79       -0.80      -0.72     Beat    10.1​
 Jun. 30 2020  -0.56       -0.56      -0.59     Missed  -5
 Mar. 31 2020  -0.73       -0.73      -4.31     Missed  -486.4
 This summary was machine generated May 6 at 18:31 GMT.  All
figures in US dollars  unless otherwise stated